2-(substituted sulfamyl) derivatives of 4-nitrobenzamide as radi

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514183, 514210, 514331, 514428, 546233, 548569, 548950, 548967, 564 87, A61K 3118, C07C14378

Patent

active

048534153

ABSTRACT:
2-(Substituted sulfamyl) derivatives of 4-nitrobenzamide are disclosed as agents that increase the sensitivity of hypoxic cancer cells to x-rays and .gamma.-radiation. Methods of preparing such compounds, protocols for administering them to human patients and animals, and pharmaceutical compositions containing them are also disclosed.

REFERENCES:
patent: 4603133 (1986-07-01), Engelhardt et al.
patent: 4647588 (1987-03-01), Engelhardt et al.
patent: 4731369 (1988-03-01), Engelhardt et al.
Narayanan, V. L. et al., Adv. Pharmacol. Chemother., 19, 174-175 (1982).
Halliwell, B. et al., Free Radicals in Biology and Medicine, Clarendon Press, Oxford, 1985, pp. 238-241.
Wardman, P., "Radiation Chemistry in the Clinic: Hypoxic Cell Radiosensitizers for Radiotherapy", manuscript to be published.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-(substituted sulfamyl) derivatives of 4-nitrobenzamide as radi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-(substituted sulfamyl) derivatives of 4-nitrobenzamide as radi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(substituted sulfamyl) derivatives of 4-nitrobenzamide as radi will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-131926

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.